Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax
Clinical trial NCT07407660 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07407660
- Sponsor
- Peking University People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-02-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.